View Item 

Show simple item record

Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry

dc.contributor.authorChung, Lorindaen_US
dc.contributor.authorDomsic, Robyn T.en_US
dc.contributor.authorLingala, Bharathien_US
dc.contributor.authorAlkassab, Firasen_US
dc.contributor.authorBolster, Marcyen_US
dc.contributor.authorCsuka, M. E.en_US
dc.contributor.authorDerk, Chrisen_US
dc.contributor.authorFischer, Aryehen_US
dc.contributor.authorFrech, Tracyen_US
dc.contributor.authorFurst, Daniel E.en_US
dc.contributor.authorGomberg‐maitland, Mardien_US
dc.contributor.authorHinchcliff, Moniqueen_US
dc.contributor.authorHsu, Vivienen_US
dc.contributor.authorHummers, Laura K.en_US
dc.contributor.authorKhanna, Dineshen_US
dc.contributor.authorMedsger, Thomas A.en_US
dc.contributor.authorMolitor, Jerry A.en_US
dc.contributor.authorPreston, Ioana R.en_US
dc.contributor.authorSchiopu, Elenaen_US
dc.contributor.authorShapiro, Leeen_US
dc.contributor.authorSilver, Richarden_US
dc.contributor.authorSimms, Roberten_US
dc.contributor.authorVarga, Johnen_US
dc.contributor.authorGordon, Jessica K.en_US
dc.contributor.authorSteen, Virginia D.en_US
dc.date.accessioned2014-03-05T18:19:02Z
dc.date.available2015-04-16T14:24:20Zen_US
dc.date.issued2014-03en_US
dc.identifier.citationChung, Lorinda; Domsic, Robyn T.; Lingala, Bharathi; Alkassab, Firas; Bolster, Marcy; Csuka, M. E.; Derk, Chris; Fischer, Aryeh; Frech, Tracy; Furst, Daniel E.; Gomberg‐maitland, Mardi ; Hinchcliff, Monique; Hsu, Vivien; Hummers, Laura K.; Khanna, Dinesh; Medsger, Thomas A.; Molitor, Jerry A.; Preston, Ioana R.; Schiopu, Elena; Shapiro, Lee; Silver, Richard; Simms, Robert; Varga, John; Gordon, Jessica K.; Steen, Virginia D. (2014). "Survival and Predictors of Mortality in Systemic Sclerosisâ Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry." Arthritis Care & Research 66(3): 489-495.en_US
dc.identifier.issn2151-464Xen_US
dc.identifier.issn2151-4658en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106105
dc.publisherWiley Periodicals, Inc.en_US
dc.titleSurvival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registryen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106105/1/acr22121.pdf
dc.identifier.doi10.1002/acr.22121en_US
dc.identifier.sourceArthritis Care & Researchen_US
dc.identifier.citedreferenceHachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52: 3792 – 800.en_US
dc.identifier.citedreferenceMukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088 – 93.en_US
dc.identifier.citedreferenceGalie N, Rubin L, Hoeper M, Jansa P, Al‐Hiti H, Meyer G, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double‐blind, randomised controlled trial. Lancet 2008; 371: 2093 – 100.en_US
dc.identifier.citedreferenceCondliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, et al. Connective tissue disease associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009; 179: 151 – 7.en_US
dc.identifier.citedreferenceCampo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D, et al. Hemodynamic predictors of survival in scleroderma‐related pulmonary arterial hypertension. Am J Respir Crit Care Med 2010; 182: 252 – 60.en_US
dc.identifier.citedreferenceWilliams MH, Das C, Handler CE, Akram MR, Davar J, Denton CP, et al. Systemic sclerosis associated pulmonary hypertension: improved survival in the current era. Heart 2006; 92: 926 – 32.en_US
dc.identifier.citedreferenceChung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch DB, et al. Characterization of connective tissue disease associated pulmonary arterial hypertension from the REVEAL registry: identifying systemic sclerosis as a unique phenotype. Chest 2010; 138: 1383 – 94.en_US
dc.identifier.citedreferenceKomocsi A, Vorobcsuk A, Faludi R, Pinter T, Lenkey Z, Kolto G, et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta‐analysis of observational studies. Rheumatology (Oxford) 2012; 51: 1027 – 36.en_US
dc.identifier.citedreferenceHesselstrand R, Wildt M, Ekmehag B, Wuttge DM, Scheja A. Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult. Scand J Rheumatol 2011; 40: 127 – 32.en_US
dc.identifier.citedreferenceChandra S, Shah SJ, Thenappan T, Archer SL, Rich S, Gomberg‐Maitland M. Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension. J Heart Lung Transplant 2010; 29: 181 – 7.en_US
dc.identifier.citedreferenceNgian GS, Stevens W, Prior D, Gabbay E, Roddy J, Tran A, et al. Predictors of mortality in connective tissue disease‐associated pulmonary arterial hypertension: a cohort study. Arthritis Res Ther 2012; 14: R213.en_US
dc.identifier.citedreferenceHinchcliff M, Fischer A, Schiopu E, Steen VD. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population. J Rheumatol 2011; 38: 2172 – 9.en_US
dc.identifier.citedreferenceFischer A, Bull TM, Steen VD. Practical approach to screening for scleroderma‐associated pulmonary arterial hypertension. Arthritis Care Res (Hoboken) 2012; 64: 303 – 10.en_US
dc.identifier.citedreferenceHumbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long‐term survival. Arthritis Rheum 2011; 63: 3522 – 30.en_US
dc.identifier.citedreferenceHachulla E, Launay D, Yaici A, Berezne A, de Groote P, Sitbon O, et al. Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome. Rheumatology (Oxford) 2010; 49: 940 – 4.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
acr22121.pdf
Size:
228.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.